IL113778A - Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof - Google Patents

Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof

Info

Publication number
IL113778A
IL113778A IL11377895A IL11377895A IL113778A IL 113778 A IL113778 A IL 113778A IL 11377895 A IL11377895 A IL 11377895A IL 11377895 A IL11377895 A IL 11377895A IL 113778 A IL113778 A IL 113778A
Authority
IL
Israel
Prior art keywords
group
substituted
optionally substituted
ring
nitrogenous heterocyclic
Prior art date
Application number
IL11377895A
Other languages
English (en)
Other versions
IL113778A0 (en
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of IL113778A0 publication Critical patent/IL113778A0/xx
Publication of IL113778A publication Critical patent/IL113778A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11377895A 1994-05-20 1995-05-18 Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof IL113778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10719094 1994-05-20

Publications (2)

Publication Number Publication Date
IL113778A0 IL113778A0 (en) 1995-08-31
IL113778A true IL113778A (en) 1999-09-22

Family

ID=14452758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11377895A IL113778A (en) 1994-05-20 1995-05-18 Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof

Country Status (21)

Country Link
US (3) US5733918A (no)
EP (1) EP0713870B1 (no)
KR (1) KR100190732B1 (no)
CN (1) CN1131216C (no)
AT (1) ATE203236T1 (no)
AU (1) AU685631B2 (no)
CA (1) CA2167382C (no)
DE (1) DE69521770T2 (no)
DK (1) DK0713870T3 (no)
ES (1) ES2158109T3 (no)
FI (1) FI111721B (no)
GR (1) GR3036795T3 (no)
HU (1) HU218308B (no)
IL (1) IL113778A (no)
NO (1) NO305555B1 (no)
NZ (1) NZ285448A (no)
PT (1) PT713870E (no)
RU (1) RU2124017C1 (no)
TW (1) TW440562B (no)
WO (1) WO1995032187A1 (no)
ZA (1) ZA954077B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
US6956035B2 (en) * 2001-08-31 2005-10-18 Inotek Pharmaceuticals Corporation Isoquinoline derivatives and methods of use thereof
US20030096833A1 (en) * 2001-08-31 2003-05-22 Jagtap Prakash G. Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
EP1436293B1 (en) 2001-10-05 2006-02-01 F. Hoffmann-La Roche Ag Polycyclic compounds having anti-tumor activity
US6946472B2 (en) * 2002-04-30 2005-09-20 Hoffman-La Roche Inc. Polycyclic compounds exhibiting anti-tumor activities
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
AU2004258801A1 (en) * 2003-02-28 2005-02-03 Inotek Pharmaceuticals Corporation Tetracyclic Benzamide Derivatives and methods of use thereof
EP1722797A4 (en) * 2004-02-26 2008-03-19 Inotek Pharmaceuticals Corp ISOCHINOLINE DERIVATIVES AND METHOD FOR THE APPLICATION THEREOF
WO2005082079A2 (en) * 2004-02-26 2005-09-09 Inotek Pharmaceuticals Corporation Tetracyclic lactam derivatives and uses thereof
JP2008503466A (ja) * 2004-06-16 2008-02-07 イノテック ファーマシューティカルズ コーポレイション 勃起不全または尿失禁を治療または予防する方法
US7790895B2 (en) * 2005-02-24 2010-09-07 Janssen Pharmaceutica Nv Quinoline derivatives as potassium ion channel openers
US20060287311A1 (en) * 2005-02-25 2006-12-21 Inotek Pharmaceuticals Corporation Tetracyclic Sulfonamide Compounds and methods of use thereof
KR20070116011A (ko) * 2005-02-25 2007-12-06 이노텍 파마슈티컬스 코포레이션 테트라사이클릭 아미노 및 카복사미도 화합물 및 이의 이용방법
KR20070116016A (ko) * 2005-02-25 2007-12-06 이노텍 파마슈티컬스 코포레이션 이소퀴놀린 화합물 및 그의 이용 방법
JP2009506060A (ja) * 2005-08-24 2009-02-12 イノテック ファーマシューティカルズ コーポレイション インデノイソキノリノン類縁体及びそれらの使用方法
CA2677046A1 (en) * 2007-02-28 2008-09-04 Inotek Pharmaceuticals Corporation Indenoisoquinolinone analogs and methods of use thereof
CN103102304B (zh) * 2013-01-19 2015-03-11 安徽师范大学 N-磺酰基取代四氢异喹啉衍生物的制备方法
WO2015025936A1 (ja) 2013-08-22 2015-02-26 大鵬薬品工業株式会社 新規キノリン置換化合物
JOP20190073A1 (ar) 2016-10-31 2019-04-07 Taiho Pharmaceutical Co Ltd مثبط انتقائي لمستقبل عامل نمو بشروي (egfr) لطافر إدخال exon 20
WO2019045036A1 (ja) 2017-09-01 2019-03-07 大鵬薬品工業株式会社 エクソン18及び/又はエクソン21変異型egfr選択的阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds

Also Published As

Publication number Publication date
HUT75651A (en) 1997-05-28
CA2167382A1 (en) 1995-11-30
NZ285448A (en) 1997-11-24
US5733918A (en) 1998-03-31
ATE203236T1 (de) 2001-08-15
FI111721B (fi) 2003-09-15
EP0713870B1 (en) 2001-07-18
DE69521770D1 (de) 2001-08-23
EP0713870A1 (en) 1996-05-29
KR100190732B1 (ko) 1999-06-01
EP0713870A4 (en) 1996-12-18
DK0713870T3 (da) 2001-09-24
NO960239L (no) 1996-03-18
CN1130903A (zh) 1996-09-11
DE69521770T2 (de) 2002-05-23
GR3036795T3 (en) 2002-01-31
HU218308B (en) 2000-07-28
TW440562B (en) 2001-06-16
AU2454295A (en) 1995-12-18
AU685631B2 (en) 1998-01-22
FI960280A (fi) 1996-03-18
IL113778A0 (en) 1995-08-31
FI960280A0 (fi) 1996-01-19
PT713870E (pt) 2001-11-30
RU2124017C1 (ru) 1998-12-27
KR960703864A (ko) 1996-08-31
NO305555B1 (no) 1999-06-21
CN1131216C (zh) 2003-12-17
ES2158109T3 (es) 2001-09-01
ZA954077B (en) 1996-01-19
WO1995032187A1 (fr) 1995-11-30
CA2167382C (en) 1999-08-31
NO960239D0 (no) 1996-01-19
US6028079A (en) 2000-02-22
US5710162A (en) 1998-01-20

Similar Documents

Publication Publication Date Title
IL113778A0 (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
AU6052594A (en) New heterocyclic compounds
ATE128975T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente.
NO940737L (no)
IL89929A0 (en) Beta-lactam derivatives,their preparation and pharmaceutical compositions containing them
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
AU6158486A (en) Dihydro pyridine derivatives
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
CA2166326A1 (en) Pyridazinone derivatives
WO2001022951A3 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
EP0785191A4 (en) INDANE FUSION DERIVATIVES AND THEIR SALTS
DE69634004D1 (de) Verknüpfte polycyclische heterocyclische verbindungen
AU7332996A (en) Therapeutics for thrombocytopenia
CA2202031A1 (en) Condensed indan derivatives and salts thereof
MX9703112A (es) Nitro-benzamidas utiles como agentes antiarritmicos.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees